nodes	percent_of_prediction	percent_of_DWPC	metapath
Thiabendazole—Enuresis—Ifosfamide—germ cell cancer	0.0565	0.0565	CcSEcCtD
Thiabendazole—Numbness—Vinblastine—germ cell cancer	0.027	0.027	CcSEcCtD
Thiabendazole—Sensory loss—Vinblastine—germ cell cancer	0.0258	0.0258	CcSEcCtD
Thiabendazole—Cholestasis—Ifosfamide—germ cell cancer	0.0213	0.0213	CcSEcCtD
Thiabendazole—Liver injury—Cisplatin—germ cell cancer	0.0165	0.0165	CcSEcCtD
Thiabendazole—Numbness—Etoposide—germ cell cancer	0.0154	0.0154	CcSEcCtD
Thiabendazole—Sensory loss—Etoposide—germ cell cancer	0.0147	0.0147	CcSEcCtD
Thiabendazole—Hepatic failure—Dactinomycin—germ cell cancer	0.0142	0.0142	CcSEcCtD
Thiabendazole—Hepatocellular injury—Cisplatin—germ cell cancer	0.0139	0.0139	CcSEcCtD
Thiabendazole—Hepatic failure—Ifosfamide—germ cell cancer	0.013	0.013	CcSEcCtD
Thiabendazole—Hypoaesthesia—Vinblastine—germ cell cancer	0.0112	0.0112	CcSEcCtD
Thiabendazole—Haematuria—Bleomycin—germ cell cancer	0.0101	0.0101	CcSEcCtD
Thiabendazole—Stevens-Johnson syndrome—Dactinomycin—germ cell cancer	0.00977	0.00977	CcSEcCtD
Thiabendazole—Hypoaesthesia—Bleomycin—germ cell cancer	0.00944	0.00944	CcSEcCtD
Thiabendazole—Hyperglycaemia—Ifosfamide—germ cell cancer	0.00914	0.00914	CcSEcCtD
Thiabendazole—Stevens-Johnson syndrome—Ifosfamide—germ cell cancer	0.00895	0.00895	CcSEcCtD
Thiabendazole—Flushing—Bleomycin—germ cell cancer	0.0088	0.0088	CcSEcCtD
Thiabendazole—Leukopenia—Vinblastine—germ cell cancer	0.00875	0.00875	CcSEcCtD
Thiabendazole—Haematuria—Ifosfamide—germ cell cancer	0.00861	0.00861	CcSEcCtD
Thiabendazole—Chills—Bleomycin—germ cell cancer	0.00851	0.00851	CcSEcCtD
Thiabendazole—Convulsion—Vinblastine—germ cell cancer	0.00847	0.00847	CcSEcCtD
Thiabendazole—Erythema multiforme—Dactinomycin—germ cell cancer	0.00837	0.00837	CcSEcCtD
Thiabendazole—Flushing—Dactinomycin—germ cell cancer	0.00821	0.00821	CcSEcCtD
Thiabendazole—Chills—Dactinomycin—germ cell cancer	0.00794	0.00794	CcSEcCtD
Thiabendazole—Visual impairment—Ifosfamide—germ cell cancer	0.00781	0.00781	CcSEcCtD
Thiabendazole—Erythema multiforme—Ifosfamide—germ cell cancer	0.00767	0.00767	CcSEcCtD
Thiabendazole—Anorexia—Vinblastine—germ cell cancer	0.00761	0.00761	CcSEcCtD
Thiabendazole—Tinnitus—Ifosfamide—germ cell cancer	0.00756	0.00756	CcSEcCtD
Thiabendazole—Flushing—Ifosfamide—germ cell cancer	0.00752	0.00752	CcSEcCtD
Thiabendazole—Leukopenia—Bleomycin—germ cell cancer	0.00739	0.00739	CcSEcCtD
Thiabendazole—Chills—Ifosfamide—germ cell cancer	0.00727	0.00727	CcSEcCtD
Thiabendazole—Stevens-Johnson syndrome—Etoposide—germ cell cancer	0.00707	0.00707	CcSEcCtD
Thiabendazole—Jaundice—Etoposide—germ cell cancer	0.00695	0.00695	CcSEcCtD
Thiabendazole—Decreased appetite—Vinblastine—germ cell cancer	0.00694	0.00694	CcSEcCtD
Thiabendazole—Leukopenia—Dactinomycin—germ cell cancer	0.00689	0.00689	CcSEcCtD
Thiabendazole—Confusional state—Bleomycin—germ cell cancer	0.0068	0.0068	CcSEcCtD
Thiabendazole—Anaphylactic shock—Bleomycin—germ cell cancer	0.00674	0.00674	CcSEcCtD
Thiabendazole—Visual impairment—Cisplatin—germ cell cancer	0.00674	0.00674	CcSEcCtD
Thiabendazole—Vision blurred—Ifosfamide—germ cell cancer	0.00665	0.00665	CcSEcCtD
Thiabendazole—Feeling abnormal—Vinblastine—germ cell cancer	0.00658	0.00658	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Vinblastine—germ cell cancer	0.00653	0.00653	CcSEcCtD
Thiabendazole—Tinnitus—Cisplatin—germ cell cancer	0.00652	0.00652	CcSEcCtD
Thiabendazole—Lymphadenopathy—Methotrexate—germ cell cancer	0.0065	0.0065	CcSEcCtD
Thiabendazole—Flushing—Cisplatin—germ cell cancer	0.00649	0.00649	CcSEcCtD
Thiabendazole—Angioedema—Ifosfamide—germ cell cancer	0.00645	0.00645	CcSEcCtD
Thiabendazole—Anorexia—Bleomycin—germ cell cancer	0.00642	0.00642	CcSEcCtD
Thiabendazole—Hypoaesthesia—Etoposide—germ cell cancer	0.00637	0.00637	CcSEcCtD
Thiabendazole—Leukopenia—Ifosfamide—germ cell cancer	0.00632	0.00632	CcSEcCtD
Thiabendazole—Abdominal pain—Vinblastine—germ cell cancer	0.00631	0.00631	CcSEcCtD
Thiabendazole—Hypotension—Bleomycin—germ cell cancer	0.0063	0.0063	CcSEcCtD
Thiabendazole—Hepatic failure—Methotrexate—germ cell cancer	0.00617	0.00617	CcSEcCtD
Thiabendazole—Convulsion—Ifosfamide—germ cell cancer	0.00612	0.00612	CcSEcCtD
Thiabendazole—Erythema multiforme—Etoposide—germ cell cancer	0.00605	0.00605	CcSEcCtD
Thiabendazole—Anorexia—Dactinomycin—germ cell cancer	0.00599	0.00599	CcSEcCtD
Thiabendazole—Flushing—Etoposide—germ cell cancer	0.00594	0.00594	CcSEcCtD
Thiabendazole—Hypersensitivity—Vinblastine—germ cell cancer	0.00588	0.00588	CcSEcCtD
Thiabendazole—Decreased appetite—Bleomycin—germ cell cancer	0.00586	0.00586	CcSEcCtD
Thiabendazole—Confusional state—Ifosfamide—germ cell cancer	0.00581	0.00581	CcSEcCtD
Thiabendazole—Anaphylactic shock—Ifosfamide—germ cell cancer	0.00576	0.00576	CcSEcCtD
Thiabendazole—Chills—Etoposide—germ cell cancer	0.00575	0.00575	CcSEcCtD
Thiabendazole—Vision blurred—Cisplatin—germ cell cancer	0.00573	0.00573	CcSEcCtD
Thiabendazole—Asthenia—Vinblastine—germ cell cancer	0.00573	0.00573	CcSEcCtD
Thiabendazole—Feeling abnormal—Bleomycin—germ cell cancer	0.00555	0.00555	CcSEcCtD
Thiabendazole—Anorexia—Ifosfamide—germ cell cancer	0.00549	0.00549	CcSEcCtD
Thiabendazole—Decreased appetite—Dactinomycin—germ cell cancer	0.00546	0.00546	CcSEcCtD
Thiabendazole—Diarrhoea—Vinblastine—germ cell cancer	0.00546	0.00546	CcSEcCtD
Thiabendazole—Leukopenia—Cisplatin—germ cell cancer	0.00545	0.00545	CcSEcCtD
Thiabendazole—Fatigue—Dactinomycin—germ cell cancer	0.00542	0.00542	CcSEcCtD
Thiabendazole—Hypotension—Ifosfamide—germ cell cancer	0.00538	0.00538	CcSEcCtD
Thiabendazole—Dizziness—Vinblastine—germ cell cancer	0.00528	0.00528	CcSEcCtD
Thiabendazole—Convulsion—Cisplatin—germ cell cancer	0.00527	0.00527	CcSEcCtD
Thiabendazole—Feeling abnormal—Dactinomycin—germ cell cancer	0.00518	0.00518	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.00514	0.00514	CcSEcCtD
Thiabendazole—Somnolence—Ifosfamide—germ cell cancer	0.00512	0.00512	CcSEcCtD
Thiabendazole—Vomiting—Vinblastine—germ cell cancer	0.00507	0.00507	CcSEcCtD
Thiabendazole—Decreased appetite—Ifosfamide—germ cell cancer	0.00501	0.00501	CcSEcCtD
Thiabendazole—Headache—Vinblastine—germ cell cancer	0.005	0.005	CcSEcCtD
Thiabendazole—Leukopenia—Etoposide—germ cell cancer	0.00499	0.00499	CcSEcCtD
Thiabendazole—Abdominal pain—Dactinomycin—germ cell cancer	0.00497	0.00497	CcSEcCtD
Thiabendazole—Fatigue—Ifosfamide—germ cell cancer	0.00497	0.00497	CcSEcCtD
Thiabendazole—Anaphylactic shock—Cisplatin—germ cell cancer	0.00497	0.00497	CcSEcCtD
Thiabendazole—Hypersensitivity—Bleomycin—germ cell cancer	0.00497	0.00497	CcSEcCtD
Thiabendazole—Asthenia—Bleomycin—germ cell cancer	0.00484	0.00484	CcSEcCtD
Thiabendazole—Convulsion—Etoposide—germ cell cancer	0.00483	0.00483	CcSEcCtD
Thiabendazole—Pruritus—Bleomycin—germ cell cancer	0.00477	0.00477	CcSEcCtD
Thiabendazole—Feeling abnormal—Ifosfamide—germ cell cancer	0.00475	0.00475	CcSEcCtD
Thiabendazole—Nausea—Vinblastine—germ cell cancer	0.00474	0.00474	CcSEcCtD
Thiabendazole—Anorexia—Cisplatin—germ cell cancer	0.00473	0.00473	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.00471	0.00471	CcSEcCtD
Thiabendazole—Hypotension—Cisplatin—germ cell cancer	0.00464	0.00464	CcSEcCtD
Thiabendazole—Hypersensitivity—Dactinomycin—germ cell cancer	0.00463	0.00463	CcSEcCtD
Thiabendazole—Confusional state—Etoposide—germ cell cancer	0.00459	0.00459	CcSEcCtD
Thiabendazole—Abdominal pain—Ifosfamide—germ cell cancer	0.00455	0.00455	CcSEcCtD
Thiabendazole—Anaphylactic shock—Etoposide—germ cell cancer	0.00455	0.00455	CcSEcCtD
Thiabendazole—Asthenia—Dactinomycin—germ cell cancer	0.00451	0.00451	CcSEcCtD
Thiabendazole—Anorexia—Etoposide—germ cell cancer	0.00434	0.00434	CcSEcCtD
Thiabendazole—Decreased appetite—Cisplatin—germ cell cancer	0.00432	0.00432	CcSEcCtD
Thiabendazole—Diarrhoea—Dactinomycin—germ cell cancer	0.0043	0.0043	CcSEcCtD
Thiabendazole—Vomiting—Bleomycin—germ cell cancer	0.00429	0.00429	CcSEcCtD
Thiabendazole—Drowsiness—Methotrexate—germ cell cancer	0.00427	0.00427	CcSEcCtD
Thiabendazole—Hypotension—Etoposide—germ cell cancer	0.00425	0.00425	CcSEcCtD
Thiabendazole—Rash—Bleomycin—germ cell cancer	0.00425	0.00425	CcSEcCtD
Thiabendazole—Dermatitis—Bleomycin—germ cell cancer	0.00425	0.00425	CcSEcCtD
Thiabendazole—Hypersensitivity—Ifosfamide—germ cell cancer	0.00424	0.00424	CcSEcCtD
Thiabendazole—Stevens-Johnson syndrome—Methotrexate—germ cell cancer	0.00424	0.00424	CcSEcCtD
Thiabendazole—Asthenia—Ifosfamide—germ cell cancer	0.00413	0.00413	CcSEcCtD
Thiabendazole—Feeling abnormal—Cisplatin—germ cell cancer	0.00409	0.00409	CcSEcCtD
Thiabendazole—Pruritus—Ifosfamide—germ cell cancer	0.00408	0.00408	CcSEcCtD
Thiabendazole—Haematuria—Methotrexate—germ cell cancer	0.00407	0.00407	CcSEcCtD
Thiabendazole—Somnolence—Etoposide—germ cell cancer	0.00404	0.00404	CcSEcCtD
Thiabendazole—Nausea—Bleomycin—germ cell cancer	0.004	0.004	CcSEcCtD
Thiabendazole—Vomiting—Dactinomycin—germ cell cancer	0.004	0.004	CcSEcCtD
Thiabendazole—Rash—Dactinomycin—germ cell cancer	0.00396	0.00396	CcSEcCtD
Thiabendazole—Decreased appetite—Etoposide—germ cell cancer	0.00395	0.00395	CcSEcCtD
Thiabendazole—Diarrhoea—Ifosfamide—germ cell cancer	0.00394	0.00394	CcSEcCtD
Thiabendazole—Fatigue—Etoposide—germ cell cancer	0.00392	0.00392	CcSEcCtD
Thiabendazole—Dizziness—Ifosfamide—germ cell cancer	0.00381	0.00381	CcSEcCtD
Thiabendazole—Feeling abnormal—Etoposide—germ cell cancer	0.00375	0.00375	CcSEcCtD
Thiabendazole—Nausea—Dactinomycin—germ cell cancer	0.00373	0.00373	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Etoposide—germ cell cancer	0.00372	0.00372	CcSEcCtD
Thiabendazole—Visual impairment—Methotrexate—germ cell cancer	0.0037	0.0037	CcSEcCtD
Thiabendazole—Vomiting—Ifosfamide—germ cell cancer	0.00366	0.00366	CcSEcCtD
Thiabendazole—Hypersensitivity—Cisplatin—germ cell cancer	0.00366	0.00366	CcSEcCtD
Thiabendazole—Rash—Ifosfamide—germ cell cancer	0.00363	0.00363	CcSEcCtD
Thiabendazole—Dermatitis—Ifosfamide—germ cell cancer	0.00363	0.00363	CcSEcCtD
Thiabendazole—Erythema multiforme—Methotrexate—germ cell cancer	0.00363	0.00363	CcSEcCtD
Thiabendazole—Abdominal pain—Etoposide—germ cell cancer	0.0036	0.0036	CcSEcCtD
Thiabendazole—Tinnitus—Methotrexate—germ cell cancer	0.00358	0.00358	CcSEcCtD
Thiabendazole—Asthenia—Cisplatin—germ cell cancer	0.00356	0.00356	CcSEcCtD
Thiabendazole—Chills—Methotrexate—germ cell cancer	0.00344	0.00344	CcSEcCtD
Thiabendazole—Nausea—Ifosfamide—germ cell cancer	0.00342	0.00342	CcSEcCtD
Thiabendazole—Diarrhoea—Cisplatin—germ cell cancer	0.0034	0.0034	CcSEcCtD
Thiabendazole—Hypersensitivity—Etoposide—germ cell cancer	0.00335	0.00335	CcSEcCtD
Thiabendazole—Asthenia—Etoposide—germ cell cancer	0.00326	0.00326	CcSEcCtD
Thiabendazole—Pruritus—Etoposide—germ cell cancer	0.00322	0.00322	CcSEcCtD
Thiabendazole—Vomiting—Cisplatin—germ cell cancer	0.00316	0.00316	CcSEcCtD
Thiabendazole—Vision blurred—Methotrexate—germ cell cancer	0.00315	0.00315	CcSEcCtD
Thiabendazole—Rash—Cisplatin—germ cell cancer	0.00313	0.00313	CcSEcCtD
Thiabendazole—Dermatitis—Cisplatin—germ cell cancer	0.00313	0.00313	CcSEcCtD
Thiabendazole—Diarrhoea—Etoposide—germ cell cancer	0.00311	0.00311	CcSEcCtD
Thiabendazole—Dizziness—Etoposide—germ cell cancer	0.00301	0.00301	CcSEcCtD
Thiabendazole—Leukopenia—Methotrexate—germ cell cancer	0.00299	0.00299	CcSEcCtD
Thiabendazole—Nausea—Cisplatin—germ cell cancer	0.00295	0.00295	CcSEcCtD
Thiabendazole—Convulsion—Methotrexate—germ cell cancer	0.00289	0.00289	CcSEcCtD
Thiabendazole—Vomiting—Etoposide—germ cell cancer	0.00289	0.00289	CcSEcCtD
Thiabendazole—Rash—Etoposide—germ cell cancer	0.00287	0.00287	CcSEcCtD
Thiabendazole—Dermatitis—Etoposide—germ cell cancer	0.00287	0.00287	CcSEcCtD
Thiabendazole—Headache—Etoposide—germ cell cancer	0.00285	0.00285	CcSEcCtD
Thiabendazole—Confusional state—Methotrexate—germ cell cancer	0.00275	0.00275	CcSEcCtD
Thiabendazole—Anaphylactic shock—Methotrexate—germ cell cancer	0.00273	0.00273	CcSEcCtD
Thiabendazole—Nausea—Etoposide—germ cell cancer	0.0027	0.0027	CcSEcCtD
Thiabendazole—Anorexia—Methotrexate—germ cell cancer	0.0026	0.0026	CcSEcCtD
Thiabendazole—Hypotension—Methotrexate—germ cell cancer	0.00255	0.00255	CcSEcCtD
Thiabendazole—Somnolence—Methotrexate—germ cell cancer	0.00242	0.00242	CcSEcCtD
Thiabendazole—Dyspepsia—Methotrexate—germ cell cancer	0.0024	0.0024	CcSEcCtD
Thiabendazole—Decreased appetite—Methotrexate—germ cell cancer	0.00237	0.00237	CcSEcCtD
Thiabendazole—Fatigue—Methotrexate—germ cell cancer	0.00235	0.00235	CcSEcCtD
Thiabendazole—Feeling abnormal—Methotrexate—germ cell cancer	0.00225	0.00225	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Methotrexate—germ cell cancer	0.00223	0.00223	CcSEcCtD
Thiabendazole—Abdominal pain—Methotrexate—germ cell cancer	0.00215	0.00215	CcSEcCtD
Thiabendazole—Hypersensitivity—Methotrexate—germ cell cancer	0.00201	0.00201	CcSEcCtD
Thiabendazole—Asthenia—Methotrexate—germ cell cancer	0.00196	0.00196	CcSEcCtD
Thiabendazole—Pruritus—Methotrexate—germ cell cancer	0.00193	0.00193	CcSEcCtD
Thiabendazole—Diarrhoea—Methotrexate—germ cell cancer	0.00186	0.00186	CcSEcCtD
Thiabendazole—Dizziness—Methotrexate—germ cell cancer	0.0018	0.0018	CcSEcCtD
Thiabendazole—Vomiting—Methotrexate—germ cell cancer	0.00173	0.00173	CcSEcCtD
Thiabendazole—Rash—Methotrexate—germ cell cancer	0.00172	0.00172	CcSEcCtD
Thiabendazole—Dermatitis—Methotrexate—germ cell cancer	0.00172	0.00172	CcSEcCtD
Thiabendazole—Headache—Methotrexate—germ cell cancer	0.00171	0.00171	CcSEcCtD
Thiabendazole—Nausea—Methotrexate—germ cell cancer	0.00162	0.00162	CcSEcCtD
